4DMedical (ASX:4DX) has announced a significant three-year commercial contract with UC San Diego Health, a top-ranked U.S. hospital for respiratory care. This partnership enables UCSD Health to incorporate 4DMedical's cutting-edge lung imaging technology into their clinical practices, underscoring the growing demand for innovative respiratory diagnostics in the U.S.
4DMedical has established a three-year agreement with UC San Diego Health, allowing the hospital to utilize its advanced lung imaging products, starting with CT-based solutions, with the potential for future expansion. This partnership not only validates the effectiveness of 4DMedical's technology but also strengthens its presence in the U.S. healthcare market. The company is poised for further commercial activities and will showcase its innovations at the upcoming RSNA event. 4DMedical's recent acquisition of Imbio enhances its AI medical imaging capabilities, aligning with its strategy to advance respiratory care technologies globally.
Securing this contract with a top-tier hospital validates 4DMedical’s diagnostic capabilities. It underscores the clinical relevance and appeal of 4DMedical’s respiratory imaging technology among U.S. clinicians.